Your browser doesn't support javascript.
loading
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
Theurl, Markus; Schgoer, Wilfried; Albrecht-Schgoer, Karin; Lener, Daniela; Wolf, Dominik; Wolf, Maria; Demetz, Egon; Tymoszuk, Piotr; Tancevski, Ivan; Fischer-Colbrie, Reiner; Franz, Wolfgang-Michael; Marschang, Peter; Kirchmair, Rudolf.
Afiliação
  • Theurl M; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria markus.theurl@i-med.ac.at rudolf.kirchmair@i-med.ac.at.
  • Schgoer W; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria.
  • Albrecht-Schgoer K; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria.
  • Lener D; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria.
  • Wolf D; Medical Clinic 3, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany Department of Haematology and Oncology, Medical University of Innsbruck, University Hospital of Internal Medicine V, Innsbruck, Austria.
  • Wolf M; Department of Haematology and Oncology, Medical University of Innsbruck, University Hospital of Internal Medicine V, Innsbruck, Austria.
  • Demetz E; Department of Clinically Immunology and Infectious Diseases, Medical University of Innsbruck, University Hospital of Internal Medicine VI, Innsbruck, Austria.
  • Tymoszuk P; Department of Clinically Immunology and Infectious Diseases, Medical University of Innsbruck, University Hospital of Internal Medicine VI, Innsbruck, Austria.
  • Tancevski I; Department of Clinically Immunology and Infectious Diseases, Medical University of Innsbruck, University Hospital of Internal Medicine VI, Innsbruck, Austria.
  • Fischer-Colbrie R; Medical University of Innsbruck, Institute of Pharmacology, Innsbruck, Austria.
  • Franz WM; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria.
  • Marschang P; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria.
  • Kirchmair R; Department of Cardiology and Angiology, Medical University of Innsbruck, University Hospital of Internal Medicine III, Anichstraße 35, Innsbruck A-6020, Austria markus.theurl@i-med.ac.at rudolf.kirchmair@i-med.ac.at.
Cardiovasc Res ; 105(1): 96-106, 2015 Jan 01.
Article em En | MEDLINE | ID: mdl-25377726
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Neuropeptídeos / Terapia Genética / Isquemia Miocárdica / Secretogranina II / Isquemia Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Neuropeptídeos / Terapia Genética / Isquemia Miocárdica / Secretogranina II / Isquemia Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article